Resident, Department of Oral and Maxillofacial Surgery, University of Washington, Seattle, WA.
Dental Student, University of Washington School of Dentistry, Seattle, WA.
J Oral Maxillofac Surg. 2021 Sep;79(9):1882-1890. doi: 10.1016/j.joms.2021.04.020. Epub 2021 Apr 22.
To review treatment of osteomyelitis of the jaw (OMJ) and determine whether antibiotic route and/or length of administration impacts resolution of infection postsurgically.
The investigators designed a retrospective cohort study enrolling a sample of patients treated at Harborview Medical Center from January 1, 2009 to December 31, 2019. The primary predictor variable was antibiotic administration route: oral (PO) only, intravenous (IV) only, IV transitioned to PO (IV + PO), or none. The secondary predictor was duration of antibiotic therapy (≤6 weeks or >6 weeks). The primary outcome variable was resolution of infection at 2 months follow-up posttreatment completion. The secondary outcome variable was number of surgeries to resolution of infection. Descriptive, bivariate, and multiple linear regression statistics were computed, with statistical significance set at P < .05.
Sixty-seven individuals met inclusion criteria (38 male), mean age 51 years (18 to 88). Forty-nine (73%) received PO antibiotics, 12 (18%) IV + PO, 3 (4%) IV, and 3 (4%) none. Both PO and IV antibiotics were associated with clinical resolution (P = .022, .005, respectively) compared with debridement alone. Antibiotic duration of ≤6 weeks compared with >6 weeks was not significant. Seventy-six percent (51 of 67) required only 1 surgery. In the multivariate logistic regression, PO was associated with clinical resolution (P = .025, OR = 5.05). Penicillin allergy (P = 0.049, OR = 0.223) and diabetes (P = .008, OR = 0.104) were adversely associated with outcome.
OMJ was successfully treated with oral antibiotics and surgery. Prescribing 6 weeks of IV antibiotics may be antiquated. Clinicians should consider oral penicillins as first line whenever possible. Further studies are recommended.
回顾下颌骨骨髓炎(OMJ)的治疗方法,并确定抗生素给药途径和/或给药时间是否会影响术后感染的消退。
研究人员设计了一项回顾性队列研究,纳入了 2009 年 1 月 1 日至 2019 年 12 月 31 日期间在 Harborview 医疗中心接受治疗的患者样本。主要预测变量是抗生素给药途径:仅口服(PO)、仅静脉内(IV)、IV 过渡到 PO(IV+PO)或无抗生素。次要预测变量是抗生素治疗持续时间(≤6 周或>6 周)。主要结局变量是治疗完成后 2 个月随访时感染的消退情况。次要结局变量是为解决感染而进行的手术次数。计算了描述性、双变量和多元线性回归统计数据,以 P<0.05 为统计学意义标准。
67 名符合纳入标准的个体(38 名男性),平均年龄 51 岁(18 至 88 岁)。49 名(73%)接受了 PO 抗生素治疗,12 名(18%)接受了 IV+PO 治疗,3 名(4%)接受了 IV 治疗,3 名(4%)未接受抗生素治疗。与单独清创术相比,PO 和 IV 抗生素均与临床缓解相关(P=0.022,P=0.005)。抗生素持续时间≤6 周与>6 周之间无显著差异。76%(51/67)仅需进行 1 次手术。在多元逻辑回归中,PO 与临床缓解相关(P=0.025,OR=5.05)。青霉素过敏(P=0.049,OR=0.223)和糖尿病(P=0.008,OR=0.104)与结局呈负相关。
OMJ 成功地接受了口服抗生素和手术治疗。开具 6 周的 IV 抗生素可能已经过时。临床医生应尽可能考虑使用口服青霉素作为一线药物。建议进一步研究。